跳至主要内容
临床试验/EUCTR2011-002207-15-IT
EUCTR2011-002207-15-IT进行中(未招募)不适用

A prospective study with beta-blockers and ACE-inhibitors in patients operable breast cancer experiencing mild cardiac toxicity during treatment with anthracycline and/or trastuzumab - Cardiorete

FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA IRCC DI CANDIOLO0 个研究点开始时间: 2012年3月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Women older than 18 years; Women with histological diagnosis of invasive breast cancer completely removed by surgery (any T, any N, M0); Women eligible for adjuvant and/or neoadjuvant treatment with anthracyclines and/or trastuzumab; Patients with HER-2 positive tumors assessed by immunohistochemistry and/or Fluorescent in Situ Hybridization (FISH); Adequate hematopietic, hepatic and renal function; Normal cardiac function with LVEF ³ 55% at the baseline; Signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 175
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 25

排除标准

  • Recurrent or metastatic disease; HER2 negative tumors; Concomitant cardiologic disease which would place the patient at unusual risk; LVEF < 55% at the baseline; Concurrent conditions that contraindicate cardiologic drugs used in this study; Patients with hypertension or other disease already treated with beta-blockers and/or ACE -inhibitors; Concomitant severe diseases which would place the patient at unusual risk; Patients treated with systemic investigational drugs within the past 4 weeks; Pregnancy or breast-feeding.

研究者

发起方
FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA IRCC DI CANDIOLO

相似试验

进行中(未招募)
1 期
Registry based randomized study of Beta blocker, ACE Inhibitor and Angiotensin Receptor Blocker in patients discharged with myocardial infarction with non-obstructive coronary artery disease (MINOCA-BAT)Myocardial infarction with non-obstructive coronary artery disease (MINOCA).
EUCTR2018-000889-11-SEDepartment of Medical Sciences, Uppsala Universitet3,500
进行中(未招募)
1 期
Registry based randomized study of Beta blocker, ACE Inhibitor and Angiotensin Receptor Blocker in patients discharged with myocardial infarction with non-obstructive coronary artery disease (MINOCA-BAT)Myocardial infarction with non-obstructive coronary artery disease (MINOCA).
EUCTR2018-000889-11-NODepartment of Medical Sciences, Akademiska sjukhuset3,500
进行中(未招募)
1 期
Registry based randomized study of Beta blocker, ACE Inhibitor and Angiotensin Receptor Blocker in patients discharged with myocardial infarction with non-obstructive coronary artery disease (MINOCA-BAT)Myocardial infarction with non-obstructive coronary artery disease (MINOCA).
EUCTR2018-000889-11-ESDepartment of Medical Sciences, Uppsala Universitet3,500
已完成
不适用
Efficacy of beta blocker for the patients with acute coronary syndrome undergoing primary percutaneous coronary interventioacute coronary syndrome
JPRN-UMIN000010696Tosei General Hospital60
招募中
3 期
The effect of a combination of beta-blockers, angiotensin receptor blockers, and calcium channel blockers in aortic stenosisAortic stenosisCardiovascular - Other cardiovascular diseases
ACTRN12621001732875niversity of Otago1,250
A prospective study with beta-blockers and... | 临床试验